CpG island hypermethylation is maintained in human colorectal cancer cells after RNAi-mediated depletion of DNMT1

被引:77
|
作者
Ting, AH
Jair, KW
Suzuki, H
Yen, RWC
Baylin, SB [1 ]
Schuebel, KE
机构
[1] Johns Hopkins Univ, Program Cellular & Mol Med, Baltimore, MD 21231 USA
[2] Johns Hopkins Univ, Canc Biol Div, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA
关键词
D O I
10.1038/ng1365
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The role of the primary mammalian DNA methyltransferase, DNMT1, in maintaining CpG island methylation in human colon cancer cells has recently been questioned. This controversy has arisen from discrepancies between genetic knockout and RNA interference-mediated knockdown studies. Here, we re-examined the RNA interference-based approach and found that hypermethylation of single-copy genes is maintained in cells transiently and stably depleted of DNMT1.
引用
收藏
页码:582 / 584
页数:3
相关论文
共 50 条
  • [1] CpG island hypermethylation is maintained in human colorectal cancer cells after RNAi-mediated depletion of DNMT1
    Angela H Ting
    Kam-wing Jair
    Hiromu Suzuki
    Ray-Whay Chiu Yen
    Stephen B Baylin
    Kornel E Schuebel
    Nature Genetics, 2004, 36 : 582 - 584
  • [2] CpG methylation is maintained in human cancer cells lacking DNMT1
    Ina Rhee
    Kam-Wing Jair
    Ray-Whay Chiu Yen
    Christoph Lengauer
    James G. Herman
    Kenneth W. Kinzler
    Bert Vogelstein
    Stephen B. Baylin
    Kornel E. Schuebel
    Nature, 2000, 404 : 1003 - 1007
  • [3] CpG methylation is maintained in human cancer cells lacking DNMT1
    Rhee, I
    Jair, KW
    Yen, RWC
    Lengauer, C
    Herman, JG
    Kinzler, KW
    Vogelstein, B
    Baylin, SB
    Schuebel, KE
    NATURE, 2000, 404 (6781) : 1003 - 1007
  • [4] Genetic depletion of DNMT1 reveals a DNMT1 threshold controlling DNA methylation in human cells
    Cai, Yi
    Tsai, Hsing-Chen
    Yen, Ray-Whay
    Xia, Limin
    Zhang, Yang
    Baylin, Stephen
    CANCER RESEARCH, 2015, 75
  • [5] DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells
    Robert, MF
    Morin, S
    Beaulieu, N
    Gauthier, F
    Chute, IC
    Barsalou, A
    MacLeod, AR
    NATURE GENETICS, 2003, 33 (01) : 61 - 65
  • [6] DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells
    Marie-France Robert
    Steves Morin
    Normand Beaulieu
    France Gauthier
    Ian C. Chute
    Annie Barsalou
    A. Robert MacLeod
    Nature Genetics, 2003, 33 : 61 - 65
  • [7] RNAi-mediated ERBB2 gene knockdown sensitizes human colorectal cancer cells to radiation
    Zhao, Dong-Li
    Dang, Cheng-Xue
    Sui, Yan-Xia
    MOLECULAR MEDICINE REPORTS, 2012, 5 (03) : 866 - 872
  • [8] Does chemotherapeutics contribute to DNMT1 expression level in colorectal cancer cells
    Varol, Nuray
    Terzi, Suna Arikan
    Soylemez, Zafer
    Yildiz, Handan
    Ozdemir, Mujgan
    Solak, Mustafa
    CANCER RESEARCH, 2017, 77
  • [9] Progesterone receptor gene inactivation and CpG island hypermethylation in human leukemia cancer cells
    Liu, ZJ
    Zhang, XB
    Zhang, Y
    Yang, X
    FEBS LETTERS, 2004, 567 (2-3) : 327 - 332
  • [10] A requirement for DICER to maintain full promoter CpG island hypermethylation in human cancer cells
    Ting, Angela H.
    Suzuki, Hiromu
    Cope, Leslie
    Schuebel, Kornel E.
    Lee, Byron H.
    Toyota, Minoru
    Imai, Kohzoh
    Shinomura, Yasuhisa
    Tokino, Takashi
    Baylin, Stephen B.
    CANCER RESEARCH, 2008, 68 (08) : 2570 - 2575